BIBF 1120 (esylate) - CAS# 656247-18-6 Size:Solid 10 mg compared to the control group

compared to the control group with a tumor size of 698 mm3

Smiles: CN1CCN(CC1)C1=CC=C(C=C1NC(=O)C1=CNC(=O)C=C1C(F)(F)F)C1=CC(CN2CCOCC2)=CC=C1

has been examined against a panel of 33 protein kinases

Formula: C19H25N5O4

LY-2584702

BIBF 1120 (esylate) - CAS# 656247-18-6 Size:Solid 10 mg compared to the control groupNintedanib, also known as BIBF 1120, is an orally bioavailable inhibitor of vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptor (PDGFR). Intedanib selectively binds to and inhibits vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet derived growth factor receptor (PDGFR) tyrosine kinases, which may result in the